Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06788314 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Enalapril in Treatment of Venous Malformations

Study acronym: EVA
StatusRecruiting
PhasePhase 2
Started2025-02-01
View on ClinicalTrials.gov ↗

Amendment history

2025-03-27
Not Yet Recruiting→Recruiting Study Identification, Study Status, Oversight, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Study sites0→1
2025-01-16
Original filing
The goal of this clinical trial is to explore if enalapril can be used to treat painful venous malformations. The main question it aims to answer are: \- Can enalapril reduce pain and volume of the malformation and increase quality of life in patients with painful venous malformations? Participants will: Receive a dose of enalapril 5 mg once daily. If it doesn't have effect the dose of enalapril will be increased to 10 mg daily after 3 months. The treatment duration will be 12 months, with an additional follow-up of 12 months. The visit frequency will be after 1, 3, 6,9 and 12 months and then a follow up visit at 18 and 24 months. Approximately 15 participants will be screened to achieve minimum 10 enrolled participants.
Trial Details
NCT Number NCT06788314
Lead Sponsor Oslo University Hospital
Conditions Venous Malformation, Pain, Quality of Life, Vascular Malformation
Enrollment 12 participants
Start Date 2025-02-01
Primary Completion 2029-12-01 (estimated)
Study Completion 2030-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-02